The insulin pens, syringes, pumps and injectors market consist of sales of insulin pens, syringes, pumps and injectors and related services by entities (organizations, sole traders and partnerships) that produce insulin pens, syringes, pumps and injectors which are used to administer insulin to control blood glucose levels in diabetic patients. Insulin pens, syringes, pumps and injectors are reusable or disposable tools used to inject the desired dose of insulin into the blood of a diabetic patient. Insulin helps to ensure that glucose levels in the patient’s blood are adequate. Diabetes is a chronic disease that occurs either when the pancreas does not produce enough insulin or when the body cannot effectively use the insulin it produces. Insulin is a hormone that regulates blood sugar.
The global insulin pens, syringes, pumps and injectors market reached a value of nearly $16,148.7 million in 2019, having grown at a compound annual growth rate (CAGR) of 7.42% since 2015, and is expected to grow at a CAGR of 8.71% to nearly $22,553.3 million by 2023.
